Holistic Cancer Care: Successful Webinar on Cancer, Patient Navigation & Health Management

The webinar “Cancer, Patient Navigation & Health Management: From Prevention to Life Coordination” was successfully completed, presenting contemporary challenges and practices in holistic oncology care, patient navigation, and patients’ digital literacy.

The online educational initiative, organized by René Descartes College in collaboration with the Kapa3 Cancer Patient Guidance Center, highlighted the importance of a human-centered approach to cancer, patient navigation, digital innovation, and the enhancement of patients’ digital literacy, combining scientific knowledge with practical support at every stage of the disease.

Holistic cancer care integrates scientific knowledge with practical support at all stages of the disease, enhancing patient engagement and quality of life.

During the webinar, the speakers shared valuable insights and experiences:

Maria Gazouli, PhD – Professor of Biology-Genetics-Nanomedicine:
She emphasized that cancer is a chronic, multifactorial disease where quality of life is as important as survival. The holistic approach treats the person as a whole—physically, psychologically, socially, and environmentally—and requires an interdisciplinary team with active patient participation in every decision. She highlighted the importance of personalized medicine and the role of family support.

Dr. Christos A. Frantzidis – Assistant Professor, University of Lincoln:
He presented CREATE, a comprehensive digital system that transforms patients’ daily experiences into valuable knowledge for clinicians, supporting timely interventions and personalized care. He stressed that artificial intelligence does not replace humans but assists clinicians in safe decision-making, reduces workload, and improves patients’ quality of life.

Dr. Maria Lavdaniti, PhD – Professor of Clinical Nursing, International Hellenic University (IHU):
She underscored the critical role of the oncology nurse in administering therapies, managing symptoms, and providing psychosocial support to patients and their families. She emphasized the importance of continuous patient education, managing long-term side effects, and interdisciplinary collaboration to improve quality of life.

Dr. Vasiliki Kapaki – Professor of Health Economics, René Descartes College:
She highlighted the role of technology in oncology, from prevention and screening to treatment and post-therapy care. She stressed that digital literacy is a prerequisite for health equity, enabling patients to understand risks, participate in decision-making, and safely follow their therapeutic pathways.

Evangelia Bista, PhD, Co-Founder of Kapa3:
She presented the work and mission of Kapa3, which supports over 7,000 families and 1,500 patients in Greece, offering guidance, information on patients’ rights, psychological support, and personalized digital tools. Her presentation included the main pillars of Kapa3’s work—website, request management, educational programs—as well as the organization’s 2026 action plans, such as Wellness in Motion, Cancer Wellness Open House Day, and digital innovations with AI and personalized service systems.

Ms. Bista highlighted that upgraded digital services with AI tools, such as Myrto, the first digital assistant/chatbot in Greece, part of Kapa3’s 2026 projects, will enable personalized services based on patient profiles, streamline processes, and reduce bureaucracy. It is clear that, combined with human guidance, the development of digital literacy is a key tool for equitable access, quality of life, and active patient engagement throughout the disease.

The webinar concluded with an open discussion and Q&A, giving participants the opportunity to interact with the speakers and exchange experiences. The initiative emphasized that technology and digital literacy do not replace humans but enhance guidance, safety, and equity in care, while holistic care remains at the center of every initiative.

We sincerely thank René Descartes College for hosting and flawlessly organizing the event, as well as all the outstanding speakers for sharing their knowledge and inspiration with the audience.

You can find some screenshots from the webinar below:

You can find the Press Release file here

World Cancer Day: United by Our Uniqueness

Every year on 4 February, World Cancer Day invites us to reflect on one of the greatest challenges of modern public health.

The goal is not only to confront cancer as a disease, but to face it with knowledge, empathy and shared responsibility. Because cancer touches millions of lives in countless ways, yet it does not define who we are. We are more than a diagnosis, more than a number.

World Cancer Day was established in 2000, following the World Summit Against Cancer for the New Millennium in Paris. It is a core element of the Paris Charter Against Cancer — a global commitment to advancing research, prevention, patient care, awareness and international mobilisation. Since then, the day has served as a reminder that addressing cancer requires long-term vision, cooperation and consistency.

This year’s message, “United by Unique”, highlights a fundamental truth: cancer is not only a medical event.

It is a deeply personal experience. Behind every diagnosis lies a unique human story — stories of fear and loss, but also of resilience, care, love and healing. Every story counts.

Cancer Today: Facts and Challenges

Cancer remains one of the most significant public health challenges in Europe and in Greece. Data from international and European organisations underline not only the scale of the disease, but also the persistent inequalities in prevention, early detection and access to care.

In Europe, approximately 2.7 million new cancer diagnoses are recorded each year, with around 1.3 million deaths, while the economic burden exceeds €93 billion annually. In Greece, cancer is the second leading cause of death, affecting thousands of families and carrying profound social and psychological consequences.

Progress, Prevention and Hope

At the same time, scientific progress offers well-founded reasons for optimism.

Prevention and early detection remain decisive factors. Screening programmes, vaccination, healthy lifestyle choices and access to reliable information can significantly reduce the risk of certain cancers and improve treatment outcomes. In this context, knowledge is not merely information — it is power and a fundamental right.

Advances in cancer management are equally important. Personalised medicine, targeted therapies, immunotherapy and improved management of treatment side effects contribute not only to increased survival rates, but also to a better quality of life for people living with and beyond cancer. Information and education are key tools for both prevention and empowerment.

Mental health plays a crucial role as well. Diagnosis and treatment are often accompanied by anxiety, fear, sadness and emotional exhaustion — affecting not only patients, but also their caregivers. Psychosocial support, counselling services and empowerment groups are essential components of holistic cancer care, helping to preserve dignity and quality of life.

Information, research and mental health care are core pillars of modern cancer management. Indicatively, you may explore the following Kapa3 articles:

Empowerment and Action

World Cancer Day is not just a day of awareness. It is a call to action:

  • to speak openly about prevention and our health,

  • to support people living with cancer and their caregivers,

  • to seek reliable information and evidence-based sources,

  • to advocate for equal access to care and psychological support,

  • to remember that no one should face cancer alone.

Because our strength lies in solidarity — and in respecting the uniqueness of every individual.

United by our uniqueness.

References:

World Health Organization (WHO) – Cancer
https://www.who.int/health-topics/cancer

International Agency for Research on Cancer (IARC)
https://www.iarc.who.int

Union for International Cancer Control (UICC) – World Cancer Day
https://www.worldcancerday.org

European Commission – Europe’s Beating Cancer Plan
https://health.ec.europa.eu/eu-policy/health-strategies/europes-beating-cancer-plan_en

European Cancer Information System (ECIS)
https://ecis.jrc.ec.europa.eu

Hellenic Statistical Authority (ELSTAT) – Health Data
https://www.statistics.gr/en/statistics/-/publication/SHE15/

Hellenic National Public Health Organization (EODY) – Cancer & Public Health
https://eody.gov.gr/

Greek Ministry of Health – Prevention & Screening
https://www.moh.gov.gr/articles/prevention-screening

Text/adaptation: Ifiyenia Anastasiou for Kapa3

KAPA3 at the 18th Panhellenic Congress of Nutrition & Dietetics

The 18th Panhellenic Congress of Nutrition & Dietetics took place at the Athens Concert Hall from 4–6 December 2025, bringing together scientists and professionals to discuss the latest developments in nutrition under the central theme “Bridging Research and Practice.”

The Congress covered topics ranging from alternative proteins to eating disorders, through lectures, workshops, and roundtable discussions.

During the session “Co-Creating Health: Participatory Research with Cancer Patients on Nutrition and Mental Resilience”, held on Friday, 5 December in Hall MC3, participants included Andrea Paola Rojas Gil, Associate Professor of Biology – Biochemistry and Director of the Laboratory of Basic Health Sciences at the University of Peloponnese, a close KAPA3 collaborator in the field of nutrition, with the topic “Nutrition as a Tool to Support Treatment and Wellbeing: Comparison of Co-Design Programs for Oncology Patients in Greece and Colombia”; Evagelia Bista on behalf of KAPA3 with “Nutrition as a Social Determinant of Health: Inequalities, Education, Environment and Policies”; and Ioanna Sideri with “Mental Health and Strategies for Empowerment and Resilience”.

Nutrition as a Social Determinant of Health

Evagelia Bista emphasized that nutrition is not merely a personal choice but one of the most critical social determinants of health, directly affecting the prevention, progression, and quality of life of oncology patients. Nearly half of people worldwide lack access to healthy food, and socio-economic inequalities determine who can follow a nutritious diet. Greece is no exception: the economic crisis, the high cost of healthy foods, and the turn towards cheap, highly processed options have worsened the situation.

Key points highlighted in the presentation included:

  • Income, education level, and food availability determine dietary quality, with low-income households experiencing higher rates of obesity and chronic diseases.

  • A shift from the Mediterranean diet towards Western-style options due to economic and social factors.

  • A double burden for vulnerable populations: undernutrition and obesity coexist, particularly affecting those facing food insecurity.

  • Impacts on oncology patients: adequate nutrition is crucial for treatment tolerance, recovery, and quality of life, yet many patients face financial and treatment-related barriers.

Ms. Bista presented KAPA3’s actions with a focus on nutritional support and the participatory approach applied in online Experiential Sessions, conducted in collaboration with the University of Peloponnese. These sessions continue a series dedicated to holistic care for body and mind, emphasizing both nutrition and mental health for oncology patients and their caregivers.

KAPA3 underlines that nutrition cannot be seen as an individual behavior alone but as the result of social, economic, and environmental factors. Reducing inequalities and ensuring access to healthy food for all is essential for better health outcomes, especially in oncology care.

Text/Adaptation: Ifiyenia Anastasiou for Kapa3

Kapa3 Supports Digital Innovation for Oncology Patients at Morning Health Talks

On Thursday, 4 December 2025, the second Morning Health Talk titled “Health Data for Innovation in Greece: Building a Stronger Digital Health Ecosystem” took place at the National Documentation Centre (EKT) in Athens. The event was held in a hybrid format (in-person and online participation), bringing together health professionals, researchers, policymakers and technology partners from Greece and abroad.

During the event, international and Greek experiences were presented on the management and use of health data, digital transformation, and best practices for leveraging data to strengthen the country’s digital health ecosystem.

Among the speakers were:

  • Dr Athanasios Batagiannis, General Director, 3-psi

  • Georgios Dimitriou, Cluster Manager, Hellenic Digital Health Cluster

  • Dr Ioannis Koumpouros, Director of DigInHealth, University of West Attica

  • Elpida Fotiadou, Head of eHealth, IDIKA

With the contribution of the distinguished speakers, key issues were discussed, including infrastructure interoperability, the need for reliable data, bureaucratic barriers, gaps in digital literacy, the development of focused platforms and processes, faster care pathways and needs assessment, the reduction of information fragmentation, and the development of human-centred digital solutions with practical value and social acceptance.

KAPA3 presented its strategic approach, focusing on standardised procedures, data quality improvement, interdisciplinarity, and the use of digital tools to support people living with cancer, as well as on guidance, interaction, empowerment and patient participation in data utilisation processes. At every step, KAPA3 addresses key challenges such as data fragmentation, stakeholder collaboration and human-centred digital solutions—issues that are also summarised in the Good Practices Guide developed within the eHealth4Cancer project.

In summary, the main points highlighted were:

  • A human-centred approach and the application of good practices to ensure the usability and social acceptance of digital solutions.

  • Strengthening collaboration between healthcare professionals, researchers and citizens to develop reliable and functional digital infrastructures.

  • The need for systematic scientific research to address challenges such as skills gaps, limited access and data fragmentation.

The event provided an important opportunity for networking and knowledge exchange, promoting the alignment of digital health infrastructures with citizens’ needs and reinforcing KAPA3’s role as an active contributor to the digital transformation of healthcare in Greece.

Read the full Morning Health Talks 2025 press release here and view photos from the event.

Text/adaptation: Ifiyenia Anastasiou for Kapa3

Biomarkers Open New Paths in Cancer Treatment in Greece

Good news for cancer patients in Greece — access to personalized treatments is now becoming a reality.

A recent decision by the Ministry of Health (ΦΕΚ Β’ 5627/20-10-2025, Απόφαση Δ3(α) 41081/2025) approves and reimburses a wider range of biomarker tests, marking an important step forward for modern oncology care.

Read the Government Gazette here

But what are biomarkers?
They are special indicators detected through molecular tests that help doctors understand the unique characteristics of each patient’s cancer. In simple terms, biomarkers act like a “compass,” guiding doctors to choose the most effective and safest treatment for every individual.

Until now, only a few biomarkers were covered by the public health system — for example, molecular signatures that determine whether a woman with early-stage breast cancer needs chemotherapy (approved in 2018), or BRCA1/2 gene tests that reveal inherited risk for breast and ovarian cancer.

The new decision significantly expands this list, adding additional biomarkers for 39 indications. This allows oncologists to tailor treatments to the specific profile of each patient’s tumor, bringing Greece closer to international standards of personalized medicine.

KAPA3, which consistently supports patient education and empowerment, welcomes this development as a vital step toward more human-centred, targeted care.

This progress brings hope, better quality of life, and greater trust in the healthcare system. It is only the beginning, but it lays strong foundations for a future where every patient has access to the right treatment, at the right time.

Learn about patient rights via KAPA3’s extensive library here

Learn more about cancer biomarkers here

Text/Adaptation: Ifiyenia Anastasiou for Kapa3

Gut Microbiota: A Hidden Ally in Cancer Treatment

Our gut is home to trillions of microorganisms, collectively called the gut microbiota, which play a crucial role in digestion, immunity, and overall health. Excitingly, research is revealing that these tiny residents can also influence the effectiveness of cancer treatments—from immunotherapy to chemotherapy and beyond. Understanding this connection opens new possibilities for more personalized and effective cancer care.

Boosting Immunotherapy through Gut Microbes

Innovative therapies like CAR-T cell therapy, immune checkpoint inhibitors (ICIs), oncolytic viruses (OVs), and CpG-oligonucleotide immunotherapy have transformed cancer treatment in recent years. Studies show that the composition of gut microbiota can affect how well patients respond to these therapies.

For instance, certain bacteria—such as Ruminococcus, Faecalibacterium, and Akkermansia—are linked to better CAR-T outcomes, while broad-spectrum antibiotics may reduce therapy effectiveness. Similarly, gut microbes can enhance responses to ICIs by stimulating immune cells that attack tumors. OVs, which work by killing cancer cells and activating the immune system, also benefit from a healthy gut microbiota. Even CpG-based therapies are more effective when gut microbes activate immune pathways.

In short, a balanced gut microbiota can help “turn cold tumors into hot tumors,” making them more responsive to modern immunotherapies.

Gut Microbes and Traditional Treatments

Gut microbiota also affects chemotherapy and radiotherapy. Some microbes can influence drug metabolism, improving efficacy or reducing side effects. For example, bacteria like Enterococcus hirae and Barnesiella intestinihominis enhance the response to cyclophosphamide, a common chemotherapy drug, by activating immune cells.

On the other hand, disruptions in gut microbiota—often caused by antibiotics or radiation—can increase treatment toxicity, leading to issues like intestinal inflammation or mucositis. Promising strategies like fecal microbiota transplantation (FMT) and certain probiotics have shown potential to restore gut balance, reduce side effects, and improve overall outcomes.

Complementary Approaches: TCM and Probiotics

Traditional medicine can also benefit from gut microbes. Traditional Chinese Medicine (TCM) compounds, when processed by gut bacteria, can transform into more potent anti-cancer agents. Certain TCM herbs and formulas can also promote beneficial bacteria while suppressing harmful ones.

Similarly, probiotics, prebiotics, and synbiotics—foods or supplements that nourish or contain helpful bacteria—can support cancer treatment by strengthening gut immunity, reducing inflammation, and enhancing drug effectiveness. For example, in combination with chemotherapy or immunotherapy, synbiotics have been shown to reduce treatment-related side effects while boosting therapeutic benefits.

Emerging Strategies: Engineering the Microbiota

Beyond diet and probiotics, scientists are developing targeted microbiota interventions to fight cancer more precisely. These include:

  • Engineered microbes, designed to deliver anti-cancer agents directly to tumors.
  • Phage therapy, using viruses that selectively kill harmful bacteria.
  • Nanomedicine and OMVs (outer membrane vesicles), which can deliver drugs or immune-stimulating molecules to tumors while sparing healthy microbes.

These cutting-edge approaches are still under study, but they demonstrate the incredible potential of harnessing gut microbes to improve therapy effectiveness and reduce toxicity.

Looking Ahead: Precision Medicine and Microbiota

The future of cancer treatment may increasingly involve personalized microbiota strategies. By analyzing an individual’s gut bacteria and metabolites, clinicians could tailor therapies to maximize efficacy and minimize side effects. Combining microbiota profiling with multi-omics analysis, AI, and big data could allow doctors to predict treatment response and guide interventions in a way that was unimaginable just a decade ago.

While challenges remain—including differences in individual microbiotas, safety considerations, and regulatory hurdles—the potential is enormous. Gut microbiota represents a promising frontier in precision oncology, offering hope for more effective, safer, and individualized cancer care.

Read the full article here

Text/Adaptation: Ifiyenia Anastasiou for Kapa3

Scientific Seminar: Psychosocial Support after Cancer Treatment and Post-Traumatic Growth

The Psychology Laboratory of INEB/CEST (Institute of Applied Biosciences / CERTH), with the support of the Municipality of Thessaloniki, is organizing on Saturday, 1 November 2025 (10:00–15:00), at the “Manolis Anagnostakis” Hall of the Thessaloniki City Hall, the scientific seminar “Psychosocial Support after Cancer Treatment and Post-Traumatic Growth.”

The event, initiated by the Psychology Laboratory as part of the IC-GROWTH research project, focuses on the psychological and social dimensions of life after cancer treatment, highlighting good practices for care, empowerment, and post-traumatic growth.

The program includes expert presentations and an open discussion with the audience, featuring researchers, healthcare professionals, and representatives from patient associations.

Participation is free, but pre-registration is required through the following form:
Registration Form

This seminar offers a valuable opportunity for learning and sharing experiences on psychosocial support and care after cancer treatment.

Kapa3 supports initiatives that strengthen mental health and quality of life for individuals who have experienced cancer.

Date: Saturday, 1 November 2025
Time: 10:00–15:00
Location: “Manolis Anagnostakis” Hall, Thessaloniki City Hall

October 25 – World Breast Cancer Awareness Day

October 25 has been established as World Breast Cancer Awareness Day, a day dedicated to raising awareness, promoting prevention, and supporting people living with this disease. Breast cancer is the most commonly diagnosed cancer among women worldwide, affecting approximately 2.3 million women each year, with 670,000 deaths, while in Greece around 6,000 new cases are diagnosed annually (Source: Globocan 2025). These are not just numbers—they are mothers, sisters, daughters, and friends who deserve hope and dignity.

Survival chances depend on access to early detection and effective treatment: in high-income countries, the five-year survival rate exceeds 90%, while in countries such as India it is 66% and in South Africa only 40%. These inequalities highlight the urgent need for coordinated international action, as incidence and mortality are projected to rise by 40% by 2050 if current trends continue.

Breat scancer does not affect only women—around 1% of diagnoses occur in men, a fact often overlooked. Awareness and education must be inclusive so that no one is left unprotected.

The WHO Global Breast Cancer Initiative, established in 2021, works with countries to reduce breast cancer mortality by strengthening health systems and facilitating access to diagnosis and treatment.

At the same time, psychosocial support for patients and their families is crucial, as a diagnosis affects all aspects of life, from work to daily routines and mental well-being.

International Breast Cancer Awareness Day also calls on communities, health organizations, and authorities to collaborate to improve access to screening and treatment services. Raising awareness about risk factors—such as genetics, age, and lifestyle—and promoting healthy habits helps prevent the disease and reduce health inequalities.

Every individual can contribute: schedule a mammogram, remind friends to do the same, support nonprofit organizations, or participate in awareness activities. Even small gestures, like wearing a pink ribbon or sharing reliable information on social media, make a difference.

At Kapa3, we believe that every woman and person living with cancer deserves support, knowledge, and access to high-quality treatments. Through initiatives in awareness, social support, and empowerment, our goal is to build a society where no life is endangered by lack of information, resources, or care, and wher

e hope and solidarity become powerful allies in the fight against the disease.

Read more on breast cancer:

https://www.kapa3.gr/en/raising-the-standards-europe-s-qa-scheme-for-breast-cancer-services/

Understanding Breast Cancer Risk Factors: What You Can and Can’t Change

October – Breast Cancer Awareness Month

Sources: https://gco.iarc.fr/en

https://www.who.int/initiatives/global-breast-cancer-initiative

https://www.who.int/news-room/fact-sheets/detail/breast-cancer

Text/adaptation: Ifiyenia Anastasiou for Kapa3

KAPA3 at the ESMO Congress: Inspiration and Confirmation That We Are Moving Towards the Future

From October 17 to 20, we attended the ESMO World Congress in Berlin. The event stood out for the active participation of the Greek medical community, which led presentations on clinical data, Real-World Evidence, and up-to-date education in collaboration with the global oncology community. At the same time, Greek teams received awards in various areas (medical, nursing, institutional), inspiring us all with hope for the ongoing developments in oncology care.

Our main goal as KAPA3 was to focus on research addressing the real needs of the population within the framework of the global community. Collaborating with healthcare professionals from around the world allowed us to gather valuable knowledge and experiences. The intensive sessions and discussions broadened our understanding and prompted reflection on the next steps.

Key challenges identified for the patient advocacy community were:

  1. Mandatory multidisciplinary assessment before starting treatment
    No patient should begin treatment without undergoing a multidisciplinary assessment, including an oncology nurse, social scientist, and psychologist. This should be considered the minimum standard for all cancer patients.
  2. Certification and quality of multidisciplinary teams
    It is our duty to ensure that these teams meet quality standards. Their certification is undoubtedly complex. However, for us at KAPA3, multidisciplinary care is a fundamental criterion for service provision and must be certified. Quality care can significantly improve patient outcomes, as shown by clinical studies and research presented at this year’s congress, with potential improvements in overall survival of up to 10% (Sweden).

We are deeply proud that our work is guided by these standards precisely. In an era of remarkable progress in medicine and new therapies, we continue to strengthen the institution of research and multidisciplinary care, ensuring accessibility and patient-centered approaches aimed at quality of life.

This is the third time we have presented our efforts at an ESMO congress, in collaboration with the International University and the Nursing Department, highlighting our presence at every level. Meanwhile, trainings for other healthcare professionals take place annually within our organization in collaboration with Greek universities.

For Greek patients and their environment, we have not yet reached a point where the quality of care is considered a key objective for the entire oncology community. Our aim is to align with efforts across Europe so that, in the future, multidisciplinary assessments from the first day of diagnosis become standard practice within therapeutic protocols.

At KAPA3, we understand that quality care, inherently multidisciplinary, requires collective effort and collaboration between organizations and professionals to determine the best possible standards.

EGFR: An “Old Target” Gaining New Life in Cancer Research

When science moves forward step by step

Progress in oncology does not always come with dramatic announcements. Often, it is found in studies that show small but meaningful steps. One such case is a recent review in JAMA Oncology exploring new targeted therapies for head and neck cancer — a type of cancer often linked to smoking, alcohol consumption, or HPV infection. At Kapa3, we closely follow these developments to keep patients and their families responsibly informed,

Researchers focused on a protein called EGFR (Epidermal Growth Factor Receptor). Approximately 90% of patients with this type of cancer show overexpression of the protein, making it an attractive target for therapy. In the past, drugs such as cetuximab attempted to “block” EGFR activity, but results were limited. Patients experienced modest improvements without a significant increase in survival.

The new generation of research goes a step further. Combination therapies are being explored, such as targeting EGFR alongside immunotherapy (e.g., pembrolizumab), which strengthens the body’s defense against cancer cells. In early studies, this combination showed response rates around 45% and a median survival of approximately 18 months in patients for whom previous treatments had failed — results that, while not dramatic, are considered encouraging for this disease.

Scientists now understand that the success of targeted therapy depends on multiple factors. In many patients, cancer cells eventually develop resistance, “learning” to bypass the drug’s effect. In addition, cancers linked to HPV appear to behave differently from those that are not, opening new avenues for more personalized approaches.

Research is also focusing on identifying biomarkers — molecular indicators that can show which patients are most likely to benefit from a particular therapy. If these tools prove reliable, they could lead to more targeted, effective, and safer treatments in the future.

At the same time, newer forms of drugs are being tested, such as bispecific antibodies and antibody–drug conjugates, which aim to target cancer cells with greater precision. All of these efforts are still in early clinical trial stages, aiming to improve efficacy and reduce side effects.

The key message of this research is not that a “new drug that beats cancer” has been found, but that science continues to search, test, and learn. Every small step, every percentage of improvement, every new idea paves the way for future progress.

For people living with cancer — and their families — hope lies not only in major breakthroughs and new treatments but also in the certainty that thousands of researchers around the world are tirelessly working to make each next step a little closer to life. Because in science, as in life, progress is often measured not in leaps but in steady, human steps. At Kapa3, we are committed to sharing this news in a clear and useful way for everyone.

Read the review here

Sources:

Hwang W. et al. “Emerging EGFR-Targeted Therapy in Head and Neck Cancer: A Review.” JAMA Oncology (2025).
World Health Organization – Cancer Research Updates

Text/adaptation: Ifiyenia for Kapa3